A diagnosis of cancer can be overwhelming. It’s my privilege to help you face the challenges that you meet during the course of your care.”
Why do you practice oncology?
You’re going through life one way, and suddenly you’re stopped in your tracks with a medical diagnosis that requires all of your attention and some really big decisions. Knowing that, I chose to work in health care to help guide people facing the immense challenges of a life-altering diagnosis. It’s an exciting time to be a cancer doctor, as new targeted treatments and immunotherapies are revolutionizing the way cancer is treated. I’m here to help where I can as a physician and a researcher. During my training, I saw firsthand in oncology clinics that new discoveries were sorely needed. Ever since, I’ve wanted to use discoveries from the lab to develop new therapies to help those most in need.
Specialties and clinical expertise
The branch of medicine a provider practices and their areas of focus
I am a UW assistant professor of medicine in the Division of Medical Oncology. I also treat patients with various types of sarcoma. My clinical interests include research in bone and soft tissue sarcomas, targeted therapies for sarcomas and immunotherapies.
I’ve received multiple awards for my work studying sarcomas, especially vascular sarcomas. In addition to treating patients, I research the molecular drivers of sarcomas and use this knowledge to develop clinical trials, ultimately leading to new treatments for this rare group of diseases.
What's it like to work with you?
As a member of your treatment team, I strive to partner with you. I provide clear information and innovative treatment options, empowering you to make decisions that best fit your goals. Treatments today are better tolerated and often more effective than therapies of the past. As we improve our understanding of the biology of cancer, I believe we’ll see new treatments that will, in time, make cancer a manageable disease. New discoveries continually lead to more treatment options, and combining options, such as targeted therapy and immunotherapy, will lead to more cures and a better quality of life.